Public databases of the Cancer Genome Anatomy Project were used to quantify the relative gene expression levels in glioblastoma multiforme (GBM) and normal brain by Serial Analysis of Gene Expression (SAGE). Analysis revealed HC gp-39 among the genes with the most pronounced changes of expression in tumor cells. Northern hybridization confirmed the results of computer analysis and showed that enhanced expression of the HC gp-39 gene was mainly in GBMs and occasionally in anaplastic astrocytomas. Neither SAGE nor Northern analysis revealed the presence of HC gp-39 mRNA in the glioblastoma cell line, thus the detection of increased quantities of this mRNA in GBMs may be associated with activated macrophages. Since the numbers of infiltrating macrophages and small vessel density are higher in glioblastomas than in anaplastic astrocytomas or astrocytomas, the HC gp-39 gene can be used as a molecular marker in the analysis of malignant progression of astrocytic gliomas. q
Introduction
Astrocytic gliomas are highly malignant, lethal and the most common glial tumors of the central nervous system. The current picture of the molecular basis of astrocytoma formation and progression presents a complex interplay between multiple genetic events involving non-random anomalies in 1p, 7q, 9p, 10q, 11p, 13q, 17p, 19q, 22q and 22p chromosomes, inactivation of tumor suppressor genes p53 and Rb, and aberrant expression of growth factors EGF, PDGF, FGFs, VEGF and their receptors [1, 2] .
Obviously, the current knowledge recognizes only a fraction of the biological mechanisms presumed to initiate and promote astrocytic gliomas. Changes in gene expression are important determinants of normal cellular physiology and, if disturbed, directly contribute to abnormal cellular physiology, including cancer. In this context, the identification, cloning and characterization of differentially expressed genes can be expected to provide relevant and important insights into the molecular determinants of tumor initiation and progression [3, 4] .
The facilities of CGAP public databases were used for the comparison of gene expression profiles in glioblastoma multiforme and normal brain by Serial Analysis of Gene Expression (SAGE). The most pronounced overexpression in GBM was observed for the human cartilage HC gp-39 gene. Northern hybridization confirmed the results of computer analysis and showed enhanced expression of the HC gp-39 gene mainly in GBMs and sometimes in anaplastic astrocytomas.
Materials and methods

Tumor and normal tissue samples
Samples of astrocytic gliomas, WHO grade II and grade III, GBMs and other types of brain tumors were obtained from the A.P. Romodanov Institute of Neurosurgery (Kiev). Tumors were classified on the basis of review of hematoxilin and eosin stained sections of surgical specimens. World Health Organization (WHO) criteria were used to classify the tumors. Surgical specimens of histologically normal brain tissue adjacent to tumors were used as a source of normal adult human brain RNA. In all, 20 GBMs were analyzed: 17 were de novo tumors and 3 were recurrent tumors progressed from anaplastic astrocytomas (WHO grade III).
Electronic subtraction
Seven SAGE libraries of GBM (GSM696: SAGE_ Duke_GBM_H1110 H1110; GSM765: SAGE_poo-led_GBM; GSM700: SAGE_Duke_H247_Hypoxia; GSM701: SAGE_Duke_H247_normal; GSM705: SAGE_Duke_H54_lacZ; GSM704: SAGE_Duke_ H54_EGFRvIII; GSM703: SAGE_Duke_H392) and six SAGE libraries of normal human brain (GSM713: SAGE_Duke_thalamus; GSM676: SAGE_BB542_ whitematter; GSM763: SAGE_normal_pool(6th); GSM695: SAGE_Duke_BB542_normal_cerebellum; GSM761: SAGE_normal_cerebellum; GSM730: SAGE_NHA(5th) were analyzed to compare gene expression in human GBM with that of normal brain by accessing SAGEmap (NCBI web site http://www. ncbi.nlm.nih.gov/SAGE).
The UniGene database of NCBI was searched to obtain the expressed sequence tags (ESTs) containing coding regions of HC gp-39 mRNA. The EST with GenBank accession number R74158 was selected for further analysis of HC gp-39 gene expression. The selected cDNA clone (IMAGEp998P09248) was obtained from the Resource Center/Primary DataBase (RZPD) of the German Human Genome Project (Max Planck Institute of Molecular Genetics, Berlin).
RNA isolation and northern blot analysis
Total RNA was isolated from frozen tissues according to Chomczynski and Sacchi [5] . RNA (10 mg per lane) was electrophoretically separated in a 1.5% agarose gel containing 2.2 M formaldehyde and then transferred to a Hybond-N nylon membrane (Amersham Pharmacia Biotech, Austria).
32 P-labeled probe was produced with RediPrime II kit (Amersham Pharmacia Biotech) using a 1261 bp fragment of HC gp-39 cDNA obtained after digestion of the IMAGEp998P09248 plasmid by Hind III and EcoR I endonucleases. The membrane was hybridized with a 32 P-labeled HC gp-39 cDNA probe in 50% formamide, 5 £ SSC, 5 £ Denhardt's solution, 0.1% SDS and 100 mg/ml salmon sperm DNA at 42 8C overnight. Extensive washing was performed: twice with 2 £ SSC, 0.1% SDS for 15 min at room temperature; once with 2 £ SSC, 0.1% SDS for 30 min at 65 8C; and finally with 0.2 £ SSC, 0.1% SDS for 30 min at 65 8C. Subsequently, the membrane was exposed to radiographic film with an intensifying screen at 2 70 8C. The membrane was re-hybridized with a 32 P-labeled human b-actin cDNA probe as a control of RNA gel loading. Densitometric analysis of hybridization signals was performed by the Scion Image 1.62c program.
Statistical analysis
The histological grade of each glioma according to the WHO criteria, as well as the patient disease status, was determined for each sample collected. Statistical analysis of data in each group was done using the Student's test.
Results
Identification of candidate genes differentially expressed in glioblastoma multiforme
We used the CGAP databases to make the 'electronic subtraction' for many thousands of genes expressed in glioblastoma multiforme and normal brain tissues. As was reported previously by Lal et al. [6] , SAGE analysis showed more than 5-fold differences ðP , 0:001Þ in the distribution of the tags between GBM and normal brain SAGE libraries for 1% of the genes analyzed (471 of 47,174 genes).
Although many putative differentially expressed genes were revealed by electronic subtraction, we focused on the ones with the greatest differences in tag distribution since these are likely to be the most biologically important in the tumorogenesis of astrocytic gliomas. The abundance of the tags for human cartilage glycoprotein-39 (HC gp-39) gene was 56-fold when the pool of seven GBM SAGE libraries and the pool of six normal brain SAGE libraries were compared. The abundance of the tags for the HC gp-39 gene was higher (148-fold) when the pool of only GSM696 and GSM765 SAGE libraries derived from the original tumors was compared with the same pool of six normal brain SAGE libraries. As can be seen in Table 1 , there was no significant difference in the tags for the HC gp-39 gene in GBM cell line SAGE libraries, astrocytomas and some other tumors in comparison with normal brain SAGE libraries.
Analysis of differential expression of the HC gp-39 gene by Northern blot hybridization
Tumor-specific expression of the HC gp-39 gene was verified by Northern blot hybridization of a panel of brain tumor and normal brain tissue RNAs. Northern hybridization showed very high expression levels of the HC gp-39 gene found exclusively in astrocytomas of higher grades. Since only signals corresponding to the main (1.7 kb) band of HC gp-39 mRNA were used for the calculations, the overall hybridization signals with GBM samples were even more intensive than is implies in Figs. 1d and 2d , which present the relative expression of the HC gp-39 (Fig. 1) , as well as the GBM cell line U251MG (Fig. 2) . In addition to the 1.7 kb mRNA described previously in human chondrocytes and synovial cells [7] , the larger-sized transcript (about 3.0 kb) was found preferentially in samples of GBM and anaplastic astrocytoma (Figs. 1 and 2 ).
Discussion
Formation and malignant progression of astrocytic tumors are associated with alterations of a variety of genes which can act as a result of mutation, e.g. change at the DNA level, such as p53, Rb, EGFR [1] , or by modulation at the expression level [3] . The identification of genes of the latter group may yield new molecular markers for diagnostics and targets for treatment of astrocytic gliomas. Suppression subtractive hybridization [8, 9] , differential display [10] , and DNA microarray technology [11] are the most attractive methods for the identification of differentially expressed genes. On the other hand, public accessible databases, such as SAGEmap [6] and Digital Differential Display [12, 13] , were created as components of CGAP. Any user of these databases can compare the transcript populations between any of the selected libraries, using SAGE and EST analyses.
In this work we report on the differential expression of the HC gp-39 gene, identified by electronic subtraction via the Internet. Overexpression of this gene in astrocytic tumors was confirmed by Northern analysis. Previously it was shown that an increased level of HC gp-39 protein (YKL-40) reflected inflammation or tissue degradation and was found in the serum of patients with rheumatoid arthritis, osteoarthritis [14] , hepatic fibrosis [15] and atherosclerosis [16] . The analysis of mRNA distribution in human tissues showed that HC gp-39 is not chondrocyte-specific and that, under normal physiological conditions, the liver could be a major source of this protein [8] . HC gp-39 protein is synthesized also by activated macrophages [16] , present in the specific granules of neutrophils and is exocytosed by activation [17] . A high serum HC gp-39 concentration has been found also in patients with colorectal cancer [18] and recurrent breast cancer [19] .
Our results extend previous data concerning the role of HC gp-39 in malignant pathologies. Significant 714Þ; yet a high difference versus GBM ðP ¼ 0:005Þ; was rather surprising. Indeed, the anaplastic astrocytomas compose very a non-uniform group: the level of HC gp-39 mRNA was same as in astrocytomas, WHO grade II, in 11 samples, while in 4 samples of the 15 samples of anaplastic astrocytoma, the level of HC gp-39 mRNA was as high as in GBMs.
It should be pointed out that gene expression in normal brain results from a mixture of glial, neuronal and microglial cells, in addition to endothelial cells and lymphocytes. As with other known tumor markers, differences in gene expression in malignant gliomas are not unexpected. Of course the 'normal' brain tissue collected around the tumor samples may serve as a source of normal adult human brain RNA only with some precautions: gliomas are infiltrating tumors and scattered tumor cells are present far away from the dense tumor area removed during surgery. Moreover, inflammation and astrocytic activation occur in this peritumoral tissue. The differences in the expression of HC gp-39 are clearly visible when individual samples of normal brain are compared to the mean HC gp-39 mRNA level in GBMs (Fig. 3) . Nevertheless, even though this control is not absolutely reliable, increase of HC gp-39 gene expression was statistically significant. Since neither SAGE nor Northern analysis was able to reveal the presence of HC gp-39 mRNA in the glioblastoma cell line, the detection of increased quantities of this mRNA in GBMs may be associated with activated macrophages at a late stage of differentiation from blood monocytes [16, 20] . Macrophages are key participants in angiogenesis. Immunostaining of macrophages and small vessels in resected glioma specimens allowed Nishie et al. [21] to show that numbers of infiltrating macrophages and small vessel density were higher in glioblastomas than in astrocytomas or anaplastic astrocytomas. Macrophage infiltration was closely correlated with vascular density in human gliomas. In this study the highest level of HC gp-39 gene expression was found mostly in glioblastomas, WHO grade IV, and thus can be used as a molecular marker in the analysis of malignant progression of astrocytic gliomas or for GBM diagnostics. Angiogenesis is necessary for the continued growth of solid tumors and acceleration of tumor growth accompanies neovascularization [22, 23] . Development of blood vessels within tumor tissue is closely correlated with invasion and metastasis, as has been demonstrated in malignant melanoma and cancers of breast, lung, prostate, and other organs [22, 24] . On the other hand, high HC gp-39 mRNA and protein levels that are found in such different tumors as colorectal cancer [18] , recurrent breast cancer (Table 3 and Ref. [19] ), and glioblastoma multiforme (this investigation and Ref. [25] ) and are related to shorter survival of patients compared to patients with normal levels of HC gp-39, bear witness to the fact that enhanced HC gp-39 gene expression is common at least for a majority of malignant tumors in their lethal stages. HC gp-39 apparently plays some role in tumor invasion and may be useful as a marker for macrophage infiltration and neovascularization, as well as a prognostic marker of survival in monitoring patients with advanced cancer.
Larger-sized HC gp-39 transcripts in higher-grade astrocytomas most probably arise from alternative processing by use of an alternative promoter, selection of an alternative splice site or a 3 0 -polyadenylation signal. These modifications often alter the translation product or regulate mRNA stability. Production of such mRNA is an important feature of high-grade astrocytomas and presumably can be used as an additional factor for distinguishing between astrocytoma (WHO grade II) and anaplastic astrocytoma or between GBM and other types of human brain tumors in the cases of ambiguous histological diagnoses. Previously, Xua et al. [26] found preferential appearance of larger-sized transcripts for several genes in oligodendrogliomas when compared to astrocytomas and meningiomas or non-tumor gray matter. The authors suggested that the formation of larger-sized transcripts may be an important feature for distinguishing between astrocytomas and oligodendrogliomas because multiple sizes of transcripts have not been reported for astrocytomas. Our results show the occurrence of different sizes of transcripts from the HC gp-39 gene in astrocytic gliomas. In addition to HC gp-39 gene transcripts, we noted also the existence of larger-sized transcripts in higher grade astrocytomas for the ZFM1 gene encoding a transcription/splicing factor, implicated in signal transduction and activation of RNA (data not shown). Thus, these data are in contradiction to the suggestion of Xua et al. [26] and the phenomenon of multiple size transcripts is not limited only to oligodendrogliomas but also takes place in other types of brain tumors. 
